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Abstract: The Ca2+-activated phospholipid scramblase and ion channel TMEM16F is expressed in
podocytes of renal glomeruli. Podocytes are specialized cells that form interdigitating foot processes
as an essential component of the glomerular filter. These cells, which participate in generation of the
primary urine, are often affected during primary glomerular diseases, such as glomerulonephritis
and secondary hypertensive or diabetic nephropathy, which always leads to proteinuria. Because
the function of podocytes is known to be controlled by intracellular Ca2+ signaling, it is important
to know about the role of Ca2+-activated TMEM16F in these cells. To that end, we generated an
inducible TMEM16F knockdown in the podocyte cell line AB8, and produced a conditional mouse
model with knockout of TMEM16F in podocytes and renal epithelial cells of the nephron. We found
that knockdown of TMEM16F did not produce proteinuria or any obvious phenotypic changes.
Knockdown of TMEM16F affected cell death of tubular epithelial cells but not of glomerular podocytes
when analyzed in TUNEL assays. Surprisingly, and in contrast to other cell types, TMEM16F did not
control intracellular Ca2+ signaling and was not responsible for Ca2+-activated whole cell currents
in podocytes. TMEM16F levels in podocytes were enhanced after inhibition of the endolysosomal
pathway and after treatment with angiotensin II. Renal knockout of TMEM16F did not compromise
renal morphology and serum electrolytes. Taken together, in contrast to other cell types, such as
platelets, bone cells, and immune cells, TMEM16F shows little effect on basal properties of podocytes
and does not appear to be essential for renal function.
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1. Introduction
The family of TMEM16 proteins (anoctamins) consists of a completely novel type of Ca2+-regulated
ion channel/phospholipid transporter with unusual structures [1,2]. These channels/transporters
are abundant with high expression in the kidney [3,4]. Filtration and generation of primary urine
takes place in renal glomeruli, which contain podocytes, a unique cell type with interdigitating foot
processes that form a glomerular filter [5]. Primary glomerular diseases, such as glomerulonephritis
and secondary renal damage during hypertensive or diabetic nephropathy, frequently result in damage
of the glomerular filtration barrier.
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Ca2+-dependent intracellular signaling plays a key role in podocyte damage. Thus, gain-of-
function mutations in the calcium channel TRPC6 cause focal-segmental glomerulosclerosis. Besides
inherited defects in Ca2+-regulated proteins, imbalance in hormones regulating intracellular calcium,
such as angiotensin or insulin, can have harmful effects [6,7]. Angiotensin II (Ang II) increases
intracellular Ca2+ in podocytes via the angiotensin II receptor 1 (AT1R) [7]. Chronic overactivation
of the renin-angiotensin-aldosterone signaling cascade is associated with renal failure, which can be
decelerated by inhibitors of the hormonal cascade [8,9]. It is therefore important to understand the
function and regulation of Ca2+-dependent TMEM16F in podocytes.
TMEM16F belongs to a family of 10 Ca2+-regulated proteins (TMEM16A-K, anoctamin 1–10) [10].
TMEM16F is broadly expressed in many tissues, including kidney epithelial cells. TMEM16F is a
Ca2+-activated phospholipid scramblase that moves phospholipids from the inner to the outer leaflet
of the plasma membrane and vice versa. Thus, it exposes phosphatidylserine in the outer membrane
leaflet that leads to structural changes during activation of platelets, participates in membrane blebbing
and cell death, and represents an immunological eat-me signal detected by binding of annexin V [10–12].
Thus, TMEM16F and proteins of the Xk-related family, specifically Xkr8, counteract the asymmetric
bilayer composition via passive, non-directional transport [13]. The large twin pores within the
TMEM16F dimer that conduct phospholipid head groups seem to also allow the permeation of ions.
Therefore, activation of TMEM16F is paralleled by Cl− and cation currents depending on the level of
activation [12,14–16].
The lipid composition of the outer plasma membrane may change during cell death or in
response to cellular stimulation or paracrine signaling. Thus, TMEM16F induces phospholipid
scrambling during apoptosis or ATP-induced cell activation [12,17]. We showed previously that
knockdown of TMEM16F modifies phosphatidylserine exposure and cell survival in HEK293 cells
and found regulation of intracellular kinases, such as AKT-dependent signaling, by TMEM16F [18].
A conventional TMEM16F knockout mouse has been studied earlier in detail and shows defects in
bone mineralization and defects in macrophages [12]. The Ca2+-regulated TMEM16F scramblase and
ion channel is also expressed in human and murine kidneys. Given the relevance of intracellular
Ca2+ signaling and Ca2+-regulated chloride currents in podocytes, we analyzed the regulation and
function of TMEM16F in this cell type. To this end, we established an inducible TMEM16F knockdown
in a human podocyte cell line and generated a renal epithelial specific TMEM16F knockout mouse.
Compared with the renal epithelial specific knockout of TMEM16A, which induced a mild renal
phenotype, knockout of TMEM16F did not show a renal defect or any obvious phenotypic changes [3].
Knockout of TMEM16F in podocytes had no effect on Ca2+-activated Cl− currents or Ca2+ signaling,
and only slightly affected cell death when compared with other cell types [12].
2. Results
2.1. TMEM16F is Expressed in Podocytes of Human and Murine Glomeruli
Immunofluorescence demonstrates expression of TMEM16F in human and mouse glomeruli
(Figure 1). Costaining of TMEM16F and nephrin, a typical protein of the glomerular slit diaphragm,
indicates coexpression in glomerular podocytes. TMEM16F was not found to be colocalized with
nephrin in foot processes, which may correspond to the absence of changes in glomerular filtration
and the absence of proteinuria in these animals. The present results are similar to the results of a
recent study with the close paralogue TMEM16A. TMEM16A is also not colocalized with nephrin in
the foot process [3]. TMEM16F was localized both in the plasma membrane and the cytoplasm of
podocytes (also compare Figure 2D). Similar patterns of TMEM16F expression were detected in human
and mouse glomeruli.
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Figure 1. Expression of TMEM16F in human and mouse glomeruli. (A) Immunohistochemistry of 
cortical sections of an adult human kidney showing TMEM16F (green) and the podocyte marker 
nephrin (red). Cell nuclei are marked by DAPI (blue). Podocytes seem to express TMEM16F in plasma 
membrane and cytoplasm. Scale bar 10 µm. (B) Immunohistochemistry of a cortical kidney section of 
an adult mouse showing TMEM16F (green) and the podocyte marker nephrin (red). TMEM16F does 
not colocalize with nephrin in foot processes but is rather localized in the cell body of podocytes. 
2.2. Inducible Knockdown of TMEM16F in AB8 Human Podocytes 
Functional analyses of naïve podocytes are notoriously difficult. In order to examine the 
functional role of TMEM16F in podocytes, we therefore generated an inducible TMEM16F-knockout 
cell line from the immortalized human podocyte cell line AB8/13 [19]. AB8 cells express the podocyte-
specific cytoskeletal proteins nephrin and synaptopodin and form filopodia and lamellipodia. For 
knockdown of TMEM16F, an inducible knockdown (KD) was generated employing pInducer10 
vector. Five short hairpin RNA sequences were screened with regard to efficient reduction of 
TMEM16F expression. The short hairpin RNAs shTMEM16F-3 (clone 3) and shTMEM16F-5 (clone 5) 
reduced expression of TMEM16F mRNA significantly (Figure 2A,C). Expression of TMEM16A was 
not detected in AB8 cells (data not shown) and expression of the TMEM16F-independent 
phospholipid scramblase Xkr8 was not affected by shRNA (Figure 2A,B). shTMEM16F-3 and 
shTMEM16F-5 largely reduced expression of TMEM16F protein (Figure 2A,C). A doxycycline-
induction for 3–5 days was sufficient to decrease significantly TMEM16F expression, but for the 
assessment of steady state effects of TMEM16F knockdown on cellular pathways, we chose an 
induction period of 7 days. This led to a marked decrease in TMEM16F protein. Induction was also 
verified by the expression of the RFP (mCherry) cassette (Figure 3A). 
l
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analyses of naïve podocytes are notoriously difficult. In order to examine the functional
role of TMEM16F in podocytes, we therefor gen rat d a inducible TMEM16F-knockout cell line
from the immortalized human podocyte cell lin AB8/13 [19]. AB8 cells expre s the podocyte-specific
cytoskeletal prot ins nephrin a d synaptopodi and f rm filopodia and lamellipo ia. For kn ckdown
of TMEM16F, an inducible knockdown (KD) was generated employi g pIn ucer10 vector. Five short
hairpin RNA sequences were screened with regard to fficient reduction of TMEM16F expression.
he short hairpin RNAs shTMEM16F-3 (clone 3) and shTMEM16F-5 (clone 5) reduced expression
of TMEM16F mRNA significantly (Figure 2A,C). Expression of TMEM16A was not detected in
AB8 c lls (data ot shown) and expression f the TMEM16F-independent phospholipid scramblase
Xkr8 was not affected by shRNA (Figure 2A,B). shTMEM16F-3 and shTMEM16F-5 largely reduce
expression of TMEM16F protein (Figure 2A,C). A doxycycline-induction fo 3–5 days was sufficient to
decrease significantly TMEM16F expressi n, but for the assessment of steady state effects of TMEM16F
knockdown on c llular pathways, we chose an indu tion period of 7 days. This led to a marked
decrease in TMEM16F protein. Induction was also verifi d by the expression of the RFP (mCherry)
cassette (Figure 3A).
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Figure 2. Expression of TMEM16F and Xkr8 in AB8 podocytes. (A) Analysis of expression of Xkr8 and 
TMEM16F by RT-PCR in AB8 podocytes expressing TMEM16F-shRNA3 or shRNA5. (B,C) Summary 
of the expression of Xkr8 and TMEM16F in the absence or presence of doxycycline (doxy; 125 ng/mL). 
(D) Immunofluorescence of TMEM16F and Cherry fluorescence in AB8 cells in the absence and 
presence of dox. Mean ± standard error of the mean (SEM) (number of experiments). # significant 
difference when compared to -Dox (p < 0.05; unpaired Student’s t test). 
2.3. Knockdown of TMEM16F Did Not Affect Expression of Proteins Related to Cell Cycle or Cell 
Proliferation 
We have previously shown that knockdown of TMEM16F decreased the viability of HEK293 
cells [18]. Reduced viability was paralleled by enhanced phosphorylation of the serine/threonine-
specific protein kinase B, also known as Akt, at the activating T308-site, as well as other pro-
proliferative signaling pathways, including cyclin D1. Phosphorylation of p42/44 MAPK and proteins 
of the mTOR pathway, however, remained unaltered in HEK293 cells. Here, we examined the role of 
TMEM16F for expression of proteins related to pro-proliferative and pro-apoptotic pathways, but 
detected no obvious changes upon knockdown of TMEM16F (Figure 3). TMEM16F knockdown did 
not affect p42/44 MAPK phosphorylation, cleavage of pro-apoptotic caspase 3, or cleavage of poly-
ADP-Ribose-Polymerase (PARP). Also, after starvation of the cells for 48 h, no effect was observed 
by TMEM16F knockdown on the screened intracellular pathways (Figure 3, right lanes). Finally, MTT 
assays did not indicate any change in cell proliferation or viability upon knockdown of TMEM16F 
(data not shown). 
Figure 2. Expression of TMEM16F and Xkr8 in AB8 podocytes. (A) Analysis of expression of Xkr8 and
TMEM16F by RT-PCR in AB8 podocytes expressing TMEM16F-shRNA3 or shRNA5. (B,C) Summary
of the expression of Xkr8 and TMEM16F in the absence or presence of doxycycline (doxy; 125 ng/mL).
(D) Immunofluorescence of TMEM16F and Cherry fluorescence in AB8 cells in the absence and presence
of dox. Mean ± standard error of the mean (SEM) (number of experiments). # significant difference
when compared to -Dox (p < 0.05; unpaired Student’s t test).
2.3. Knockdown of TMEM16F Did Not Affect Expression of Proteins Related to Cell Cycle or Cell Proliferation
We have previously shown that knockdown of TMEM16F decreased the viability of HEK293
cells [18]. Reduced viability was paralleled by enhanced phosphorylation of the serine/threonine-
specific protein kinase B, also known as Akt, at the activating T308-site, as well as other pro-proliferative
signaling pathways, including cyclin D1. Phosphorylation of p42/44 MAPK and proteins of the mTOR
pathway, however, remained unaltered in HEK293 cells. Here, we examined the role of TMEM16F for
expression of proteins related to pro-proliferative and pro-apoptotic pathways, but detected no obvious
changes upon knockdown of TMEM16F (Figure 3). TMEM16F knockdown did not affect p42/44 MAPK
phosphorylation, cleavage of pro-apoptotic caspase 3, or cleavage of poly-ADP-Ribose-Polymerase
(PARP). Also, after starvation of the cells for 48 h, no effect was observed by TMEM16F knockdown on
the screened intracellular pathways (Figure 3, right lanes). Finally, MTT assays did not indicate any
change in cell proliferation or viability upon knockdown of TMEM16F (data not shown).
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Figure 3. Knockdown of TMEM16F in podocytes had little effects on the expression of proteins related 
to cell proliferation/cell cycle or cell death. (A) Western blot analyses of three independent lysates 
from AB8 shTMEM16F-3 cells. Samples that have been induced with Doxycycline for 7 days are 
indicated as TMEM16F KD. Cells for the samples shown in the left panel were cultured under 
standard conditions, and cells for control and knockdown samples shown on the right were starved 
in serum-free medium for 48 h prior to harvesting. Equal loading, efficient induction, and knockdown 
of the target protein TMEM16F were verified by immunoblotting for TMEM16F, red fluorescent 
protein (RFP) cassette (mCherry), and beta tubulin. Western blots were performed for p42/44 MAPK, 
Akt, phospho-p42/44 MAPK (at a long (upper blot) and a short (lower blot) exposure time), phospho-
Akt, and indicator proteins of apoptosis (cleavage of Caspase 3 and poly-ADP-Ribose-Polymerase 
(PARP)). (B) Densitometry analysis of expression of Akt and phospho-Akt relative to ß-tubulin 
(arbitrary units, au). Apart from decreased phosphorylation of AKT at T308 in starved cells, there 
were no quantitative differences in signaling proteins included in this screen. Mean ± SEM (number 
of experiments). 
2.4. Knockdown of TMEM16F Affects Cell Death in Tubular Epithelial Cells but not in Glomerular 
Podocytes 
In contrast to other cell types, proliferation of podocytes was not affected by knockdown of 
TMEM16F [18,20–22]. We performed TUNEL stainings in renal sections from wild-type (wt) and 
TMEM16F knockout animals after performing control experiments in wild-type tissue Figure 4A). 
Remarkably, no TUNEL-positive cells were detected in either wt or TMEM16F-KO podocytes 
Figure 3. Knockdown of T E 16F in podocytes had little effects on the expression of proteins
related to cell proliferation/cell cycle or cell death. (A) Western blot analyses of three independent
lysates from AB8 shTMEM16F-3 cells. Samples that have been induced with Doxycycline for 7 days
are indicated as TMEM16F KD. Cells for the samples shown in the left panel were cultured under
standard conditions, and cells for control and knockdown samples shown on the right were starved in
serum-free medium for 48 h prior to harvesting. Equal loading, efficient induction, and knockdown of
the target protein TMEM16F were verified by immunoblotting for TMEM16F, red fluorescent protein
(RFP) cassette (mCherry), and beta tubulin. Western blots were performed for p42/44 MAPK, Akt,
phospho-p42/44 MAPK (at a long (u per blot) and a short (lower blot) exposure time), phospho-Akt,
and indicator proteins of apoptosis (cleavage of Caspase 3 and poly-ADP-Ribose-Polymerase (PARP)).
(B) Densitometry an lysis of expression of Akt and phospho-Akt relative to ß-tubulin (arbitrary units,
au). Apart from decreased phosphorylation of AKT at T308 in starved cells, there were no quantitative
differences in signaling proteins included in this screen. Mean ± SEM (number of experiments).
2.4. Knockdown of TMEM16F Affects Cell Death in Tubular Epithelial Cells but not in Glomerular Podocytes
In contrast to other cell types, proliferation of podocytes was not affected by knockdown of
TMEM16F [18,20– 2]. We performed TUNE i gs in renal sections from wild-type (wt) and
TMEM16F knock ut animals after performin r l experiments in wild-type tissue Figure 4A).
Remarkably, no TUNEL-positive cells were detected in either wt or TMEM16F-KO podocytes (encircled
areas and insets (glom) in Figure 4B. In contrast, TUNEL-positive tubular epithelial cells were
detected in wild-type kidneys, which were significantly reduced in kidneys from TMEM16F−/− cells
(Figure 4B,C). Phospholipid scrambling was induced by ionomycin in AB8-TMEM16F+/+ cells, but was
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missing in AB8-TMEM16F−/− cells (Figure 4D). Finally, TNFα-induced cell death (as measured by
LDH release) was only slightly compromised in AB8-TMEM16F−/− cells. Thus, a clear role of
TMEM16F for cell death could not be detected in podocytes, which appear to have generally a lower
apoptotic activity.
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Figure 4. Cell death in renal epithelial cells. (A) Positive control (+DNAse I) and negative control (-
rTerminal Deoxynucleotidyl Transferase) for TUNEL assays. (B,C) TUNEL staining in TMEM16F+/+ 
and TMEM16F−/− kidneys. No signals were detected in glomerula of both +/+ and −/− kidneys and 
only very few TUNEL-positive cells were seen in tubules of −/− kidneys. # significant difference when 
compared to +/+ (p <0.05; unpaired Student’s t test). White circles shown in B indicate localization of 
glomeruli, which are also shown as enhanced magnified insets (glom). D) Phospholipid scrambling 
(annexinV positivity) upon stimulation with ATP (5 mM) or the Ca2+ ionophore ionomycin (5 µM) in 
AB8-TMEM16F+/+ (-dox) and AB8-TMEM16F−/− (+dox) podocytes. E) LDH (lactate dehydrogenase) 
release induced by TNFα in AB8-TMEM16F+/+ (−dox) and AB8-TMEM16F−/− (+dox) podocytes. 
Mean ± SEM (number of experiments). # significant difference when compared to −Dox (p < 0.05; 
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2.5. TMEM16F Does not Control Intracellular Ca2+ Signaling and Is not Responsible for Ca2+-Activated 
Whole-Cell Currents in Podocytes 
We examined other cellular parameters that have been demonstrated earlier to be affected by 
expression of TMEM16F. Phospholipid scrambling and whole-cell currents are induced by 
expression and activation of TMEM16F [12,15]. Moreover, TMEM16F augments agonist-induced 
Figure 4. Cell death in renal epithelial cells. (A) Positive control (+DNAse I) and negative control
(-rTerminal Deoxynucleotidyl Transferase) for TUNEL assays. (B,C) TUNEL staining in TMEM16F+/+
and TMEM16F−/− kidneys. No signals were detected in glomerula of both +/+ and −/− kidneys
and only very few TUNEL-positive cells were seen in tubules of −/− kid eys. # significant difference
when c pared to +/+ (p <0.05; unpaired Stude t’s t tes ). White circles shown in B indicate
localiz tion of glomeruli, which are also shown as enhanced magnified insets (gl m). (D) Phospholipid
scrambling (annexinV positivity) upon stimulation with ATP (5 mM) or the Ca2+ ionophore ionomycin
(5 µM) in AB8-TMEM16F+/+ (-dox) and AB8-TMEM16F−/− (+dox) podocytes. (E) LDH (lactate
dehydrogenase) release induced by TNFα in AB8-TMEM16F+/+ (−dox) and AB8-TMEM16F−/−
(+dox) podocytes. Mean ± SEM (number of experiments). # significant difference when compared to
−Dox (p < 0.05; unpaired Student’s t test).
2.5. TMEM16F Does not Control Intracellular Ca2+ Signaling and Is not Responsible for Ca2+-Activated
Whole-Cell Currents in Podocytes
We examined other cellular parameters that have been demonstrated earlier to be affected by
expression of TMEM16F. Phospholipid scrambling and whole-cell currents are induced by expression
and activation of TMEM16F [12,15]. Moreover, TMEM16F augments agonist-induced intracellular
Ca2+ signals by supporting Ca2+ influx [23–25]. We compared whole-cell currents and Ca2+ signaling
in podocytes in the presence (−doxycyclin; −DOX) or absence (+doxycycline; +DOX) of TMEM16F.
In all experiments, the experimental bath was continuously perfused (200 mL bath volume, perfusion
rate 8 mL/min) with a bicarbonate-free Ringer solution in order to reduce possible contributions
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of additional bicarbonate-transporting membrane proteins, such as those of the SLC26A family.
As the bath solution is continuously exchanged, extracellular pH changes cannot occur. The pH
was 7.4 throughout the experiment and was measured using a micro-pH meter. In the whole-cell patch
clamp experiments, an ion current was activated by an increase of intracellular Ca2+ with ionomycin
(Iono, 1 µM). Surprisingly, activation of the whole-cell current was completely independent of
TMEM16F-knockdown (+DOX), which was different to the results of many previous studies [12,16,26]
(Figure 5A,B). Moreover, tert-butyl hydroperoxide (tBHP;100 µM/2 h), which has been shown
previously to activate TMEM16F whole-cell currents, did not activate any ion currents independent of
TMEM16F knockdown by doxycycline [16,27] (Figure 5C,D). Finally, pre-incubation with Angitensin
II (AngII), which upregulates expression of TMEM16F, did not induce an TMEM16F-dependent,
Ca2+-activated whole-cell current (Figure 5E,F). Thus, it is very likely that ionomycin activates another
TMEM16 channel expressed in mouse podocytes. As there are many paralogues expressed in mouse
glomeruli (ANO 1,3,5,6,8,9), it is possible that another anoctamin (not TMEM16A or TMEM16F) is in
charge of the ionomycin-activated Cl− current. This is rather likely as niclosamide, a very powerful
inhibitor of TMEM16 proteins (Miner et al., 2017), inhibited ionomycin-activated whole-cell currents
(5.34 ± 0,84 nA; Iono; n = 4) versus 3.1 ± 0,72 nA; Iono/niclosamide; n = 4).Int. J. Mol. Sci. 2018, 19, x FOR PEER REVIEW  8 of 19 
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ROS donor and lipid peroxydizer tert-butyl hydroperoxide (tBHP;100 µM/2 h). (E,F) Summary of 
ionomycin-induced whole-cell currents and current/voltage relationships in AB8-TMEM16F+/+ 
(−dox) and AB8-TMEM16F−/− (+dox) podocytes and effect of 48 h incubation with angiotensin II 
(AngII) (1 µM). Mean ± SEM (number of experiments). * significant effect of ionomycin (p < 0.05; 
paired Student’s t test). 
 
Figure 6. Ca2+ signaling in AB8 podocytes. (A,B) Increase in intracellular Ca2+ ([Ca2+]i) by stimulation 
with ATP (10 µM), Ang II (100 nM), or hypotonic bath solution (33%) in the presence (−Dox) or 
absence (+Dox) of TMEM16F (summary curves). B) Summary of basal Ca2+ levels in two different AB8 
clones, IONO in the presence (−Dox) or absence (+Dox) of TMEM16F. (C) Summary of the effects of 
Figure 5. Ca2+-activated whole-cell currents in AB8 podocytes. (A,B) Current voltage relationships
of whole-cell ion currents and current densities activated by the Ca2+ ionophore ionomycin (1 µM)
in AB8 podocytes in the presence (−Dox) or absence (+Dox) of TMEM16F. (C,D) Current voltage
relationships of whole-cell ion currents and current densities in the absence (con) or presence of
the ROS donor and lipid peroxydizer tert-butyl hydroperoxide (tBHP;100 µM/2 h). (E,F) Summary
of ionomycin-induced whole-cell currents and current/voltage relationships in AB8-TMEM16F+/+
(−dox) and AB8-TMEM16F−/− (+dox) podocytes and effect of 48 h incubation with angiotensin II
(AngII) (1 µM). Mean ± SEM (number of experiments). * significant effect of ionomycin (p < 0.05;
paired Student’s t test).
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Intracellular Ca2+ levels were determined using Ca2+-dependent Fura2 fluorescence. To that
end, cells were loaded with Fura2 prior to the experiment and basal Ca2+ levels were measured.
Afterwards, cells were stimulated with agonists known to increase intracellular Ca2+, such as ATP
(10 µM), angiotensin II (AngII; 100 nM), or hypotonic bath solution (33% hypo) [21]. ATP and AngII,
but not 33% hypo, increased intracellular Ca2+ and demonstrated the typical peak (Ca2+ release from
endoplasmic reticulum) and plateau (store-operated Ca2+ influx) increase. Rather surprising was that
Ca2+ increase was entirely independent of TMEM16F expression as demonstrated in two independent
podocyte clones (Figure 6).
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2.6. Regulation of TMEM16F in Podocytes
Our data demonstrate that many of the TMEM16F-related cellular effects observed in freshly
isolated tissues or cultured cells are not observed in podocytes, a finding that remains currently
unexplained. We further examined whether pathological conditions are induced by altered TMEM16F
expression in podocytes and whether knockout of TMEM16F causes a renal phenotype. Glomerular
hemodynamics are substantially regulated by Ang II, and Ang II is known to affect the functional
integrity of podocytes [5,6,8,28]. TMEM16F may contribute to Ang II-induced effects on activation
and survival of podocytes. Along this line, we examined possible changes in TMEM16F expression
during exposure to Ang II. We used AB8 cells with inducible expression of FLAG-tagged human
AT1 receptors (AB8 3F-hAT1R) [29]. Low endogenous non-detectable AT1R levels were enhanced by
incubation with Ang II and additional treatment with doxycycline (Figure 7A). Moreover, both Ang II
and additional expression of AT1R strongly augmented expression of TMEM16F, which may suggest a
functional relevance of TMEM16F for Ang II-related renal disease (Figure 7A).
As some membrane proteins are regulated by endolysosomal recycling, we examined whether
inhibition of 1-phosphatidylinositol 3-phosphate 5-kinase (PIKfyve) would affect expression of
TMEME16F in AB8 podoctyes. PIKfyve is an essential enzyme of the endolysosomal pathway, which
was inhibited by YM201636 (800 nM, 5 h). Indeed, inhibition of PIKfyve led to an accumulation of
TMEM16F protein in podocytes (Figure 7B). Parallel accumulation of the nuclear pore glycoprotein
62 (p62) was used as a positive control. Finally, the inhibitor of Rho kinase (ROCK), hydroxyfasudil,
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also led to an accumulation of TMEM16F in podocytes (Figure 7C). Taken together, TMEM16F is
regulated by endolysosomal recycling in human podocytes.
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2.7. Knockout of TMEM16F in Podocytes Does Not Compromise Renal Morphology and Renal Function
The present data suggest that expression of TMEM16F in renal podocytes has little impact on
podocyte function and, in contrast to other cell types, does not affect cellular parameters, such as
Ca2+ signaling, Ca2+-activated ion currents, or cell death. In order to determine whether TMEM16F
is important for renal function, we generated a renal TMEM16F knockout mouse model (Figure 8;
c.f. Methods). Mice with the loxP-flanked TMEM16F gene, TMEM16F(lox/lox) mice, were bred
with SIX2 Cre transgenic mice [30]. SIX2 expression starts early during nephrogenesis; consequently,
the progeny lack expression of TMEM16F from the cap mesenchymal stage in all descendants that
form the renal nephron [30]. Crossbreeding of mice with a floxed TMEM16F allele with SIX2 Cre
mice led to a constitutive knockout of TMEM16F in glomerular podocytes and tubular epithelial cells
while Cre-negative littermate controls displayed normal expression of TMEM16F (Figure 9A). Renal
histology of TMEM16F−/−mice confirmed an intact structure, i.e., corticomedullary differentiation
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was intact, glomeruli and tubuli appeared normal, and renal cysts were not observed (Figure 9B).
Renal TMEM16F knockout mice grew like their wt littermates, and none of the TMEM16F−/− animals
developed albuminuria or gross proteinuria. The serum creatinine, urea nitrogen, and serum electrolyte
concentrations did not differ between TMEM16F+/+ and TMEM16F−/− animals (Figure 9C). The data
suggest that TMEM16F is not essential to maintain the selectivity of the podocyte slit membrane.Int. J. Mol. Sci. 2018, 19, x FOR PEER REVIEW  11 of 19 
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Figure 9. Lack of a renal phenotype by renal TMEM16F knockout. (A) Immunohistochemistry of
TMEM16F(flox/flox) Six2Cre mice. Cre-negative animals, which were used as a littermate control
in our study, display a normal expression of TMEM16F. Cre-positive animals (TMEM16F−/−) lack
expression of TMEM16F in the kidney parenchyma. (B) Periodic acid Schiff stain of kidney sections of
Cre-negative (control; TMEM16F+/+) and Cre-positive (TMEM16F−/−) animals. The parenchyma
appears normal and cysts are absent in the TMEM16F−/− kidney. (C) Summaries for serum creatinine,
urea nitrogen, and serum electrolyte concentrations, which did not differ between TMEM16F+/+ and
TMEM16F−/− animals. Mean ± SEM (number of experiments).
3. Discussion
TMEM16F is a C 2+-activated phospholipid scramblase and gen rates whole-cell currents when
activated by an increase in i tracellular Ca2+ [10,12,15]. TMEM16F has essential functions in platelets,
bone cells, macrophages, and T-lymphocytes [15,26,31–35]. It is essential for blood coagulation,
bone mineralization, immune defense, and protein shedding. TMEM16F also fulfills basal cellular
functions during Ca2+ signaling, volume regulation, blebbing of the plasma membrane, and cell
death [12,21,23,24,27,36]. It was therefore interesting to examine a possible role of TMEM16F in renal
epithelial cells and in particular in renal glomerular podocytes.
Rather surprisingly, knockout of TMEM16F did not compromise renal morphology and does
not seem to be essential for maintaining the selectivity of the podocyte slit membrane. Thus,
TMEM16F-knockout mice did not develop any obvious proteinuria. The present data do not provide
any evidence for a role of TMEM16F in regulation of glomerular filtration, i.e., protein filtration.
As knockout of the Ca2+-activated Cl− channel TMEM16A did not induce proteinuria or any obvious
podocyte defect in an earlier study [3], we hoped to identify the common paralogue TMEM16F as
the essential Ca2+-activated Cl− channel in podocytes. The fact that Ca2+-activated Cl− currents
are present in podocytes independent of TMEM16F suggests a role of another TMEM16 protein as
expression of CFTR was not detected. It would be interesting to examine in future studies whether
LRRC8A plays a role for Ca2+-activated whole-cell currents in renal podocytes.
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Moreover, changes in cellular properties typically related to knockdown of TMEM16F were
not observed in podocytes, albeit knockdown of TMEM16F blocked Ca2+-activated phospholipid
scrambling (Figure 4D). Thus, TMEM16F does not seem to have a major role in podocytes. Although
knockout of TMEM16F did not produce proteinuria under basal conditions, TMEM16F could still
be relevant during pathological conditions. In fact, some of the present data suggest that TMEM16F
may contribute to Ang II-induced activation and survival of podocytes. Glomerular hemodynamics
are substantially regulated by Ang II, and Ang II is known to affect the functional integrity of
podocytes [5,6,8,28]. TMEM16F may contribute to the Ang II-induced effects on activation and survival
of podocytes. At any rate, the rate of spontaneous apoptotic cell death appears to be very low in
podocytes according to the present data. Taken together, TMEM16F does not participate in the control
of renal filtration under physiological conditions. A subsequent study could examine whether an
inflammatory challenge, i.e., induction of glomerulonephritis, unmasks a role of TMEM16F.
4. Methods
4.1. Cell Culture and Generation of Inducible Cell Lines
Human immortalized podocytes (AB8/13) [19]; kindly provided by Dr. M. Saleem), HEK293
cells (Thermo Scientific, Waltham, MA, USA), and the Retro-X packing cell line GP2-293 were cultured
under standard conditions as described earlier [29]. A lentiviral system (pInducer21/10) was used for
the generation of stable inducible cell lines [29]. PInducer10 was used for stable inducible knockdown
and pInducer21 was employed for inducible overexpression as described before. In brief, short hairpin
RNA was designed with the shRNA prediction algorithm provided at http://biodev.extra.cea.fr/
DSIR/DSIR.html [37]. In total, six different short hairpin RNA fragments were generated and cloned
into the pInducer10 red fluorescent protein (RFP) plasmid as described previously [18]. The resulting
pInducer10 (RFP) plasmids encoded short hairpin RNA and a separately transcribed red fluorescent
protein (RFP). Expression of short hairpin RNA (sequences as provided previously [18] and RFP was
induced by adding 125 ng/mL doxycycline to the medium. Efficient knockdown of the target protein
TMEM16F was verified by semiquantitative RT-PCR and Western blotting.
4.2. Cell Lysates and Western Blotting
Immunoblotting was carried out as previously indicated [29]. Medium was taken off equally
confluent cell culture plates and replaced by 1× Laemmli (4% SDS, 5% 2-mercaptoethanol, 10%
glycerol, 0.002% bromophenol blue, 0.0625 M Tris-HCl; pH 6.8). Cell lysates were incubated on a
shaking plate for 30 min at room temperature. Afterwards, cell lysates were homogenized via pipetting
up and down and then frozen for at least 2 h. After boiling for 3 min, equal volumes of cell lysates
were separated on 8–15% SDS-PAGE gels (Biorad, Munich, Germany). Proteins were transferred to
a PVDF membrane (Millipore, Darmstadt, Germany) and incubated for 1 h at room temperature in
blocking buffer (5% BSA powder dissolved in TBS containing 0.05% Tween-20 (TBS-T)). The lysates
were equalized using β-tubulin (Sigma, Munich, Germany; #T2200) as loading controls. TMEM16F
(#HPA038958) and anti-FLAG (F3165) were from Sigma. Antibodies against Caspase 3 (#9665), cleaved
Capase 3 (Asp175) (#9664), PARP (#9542), cleaved PARP (#5625), p42/44 MAPK (#4695), phospho-
p42/44 MAPK (Thr202/Tyr204) (#43769), AKT (#9272), phospho- AKT (Thr308) (#2965), GAPDH
(#5174)), and LC3 I/II (#12741) were all from Cell Signaling (Frankfurt, Germany). Horseradish
peroxidase-conjugated secondary antibodies were from Dianova (Hamburg, Germany). All primary
antibodies were used in a 1:1000 dilution in TBS-T and incubated at 4 ◦C overnight. After washing
three times with TBS-T, the membrane was incubated with horseradish peroxidase-coupled secondary
antibodies (Jackson Immunoresearch, Westgrove, PA, USA) diluted 1:5000 (anti mouse) or 1:10000 (anti
rabbit) in 5% BSA powder dissolved in TBS-T for 30–60 min at room temperature. Afterwards, the blot
was washed three times with TBS-T. Western blots were developed with chemiluminescence detection
reagent (Roche, Mannheim, Germany). Signals were collected with X-ray film.
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4.3. Immunofluorescence
Immunofluorescence was performed as described earlier [29]. In brief, cells were fixed with
4% paraformaldehyde supplemented with 4% sucrose in PBS for 20 min. All steps were performed
at room temperature. Samples were washed with PBS and incubated with 50 mM NH4Cl in PBS
to quench reactive amino groups. After continued washing, cover slips were permeabilized with
PBS containing 0.2% gelatin and 0.2% TritonX-100 (PBS-TG). Then, samples were blocked with
10% goat serum diluted in PBS-TG for 20 min. Immunofluorescence staining was performed by
incubating the cover slips for one hour with primary antibodies diluted in PBS-TG containing 2% goat
serum. Afterwards, cover slips were washed in PBS-TG and incubated with fluorochrome-conjugated
secondary antibodies diluted 1:1000. Nuclei of cells were stained with DAPI (dilution 1:5000). After
washing with PBS, cover slips were rinsed in distilled water and cells were mounted in Mowiol.
Samples were examined with an Axio Observer Z1 microscope and ApoTome technology (Zeiss,
Oberkochen, Germany; objective: EC Plan Neofluar 40×/1.30*Oil DIC M27) using Axio Vision 4.7.
The TMEM16F antibody was purchased from Sigma (HPA038958), and antibodies against nephrin
were obtained from Invitrogen. For detection of TMEM16F by peroxidase reaction, sections were
incubated after exposure to anti-TMEM16F AB in a biotinylated donkey anti-rabbit antibody diluted
1:400 (Santa Cruz Biotechnology, Heidelberg, Germany). After washes, the sections were incubated
with di-aminobenzidine. Tissues were counterstained with hematoxylin (Merck, Darmstadt, Germany)
before mounting in Depex (SERVA Electrophoresis, Heidelberg, Germany). Nuclei were stained with
Hoe33342 (Sigma-Aldrich, Taufkirchen, Germany) and then mounted in DakoCytomation media.
Endogenous peroxidase activity was blocked by incubating in 3% H2O2 in PBS.
4.4. MTT assay
Determination of cytotoxicity was performed using an MTT assay. The MTT assay was performed
as previously described [18]. In brief, cells were grown on translucent flat-bottomed 96-well microtiter
plates. On the day of the experiment, cells were provided with 100 µL culture medium. For the assay,
10 µL tetrazolium MTT (3-(4,5-dimethylthiazolyl-2)-2,5-diphenyltetrazolium bromide) were added and
cells were incubated at 37 ◦C for 60 min. During this time, the yellow tetrazolium salt MTT is converted
to purple formazan crystals by intracellular reducing equivalents in metabolically active cells. After 3 h
incubation, 100 µL lysis buffer (20% sodium dodecyl sulfate, 50% N,N-dimethylformamide, containing,
0.5% acetic acid (80%), 0.4% 1N HCL) was added to each well and incubated on the shaking plate for
3 h. The optical density was assessed with a fluorescence plate reader (Tecan) at 570 nm.
4.5. Generation of Mice with LoxP-Flanked TMEM16F Gene
Conditional knockout of TMEM16A in mice was performed with approval of the federal
guidelines for animal welfare. The TMEM16F targeting construct (pTMEM16F_targ.) was designed
as follows. The mouse genomic DNA fragment, containing a 4.0 kb right flanking region including
exon 8 and intronic sequences was PCR amplified with the oligonucleotides TMEM16F_FlAd2 and
TMEM16F_FlAr2 and subcloned. The 1.2 kb left flanking region including intron 6 genomic sequences
was PCR amplified using the oligonucleotides TMEM16F_FlBd1 and TMEM16F_FlBr1 and subcloned
(compare Table 1 for list of primers). The 0.3 kb exon-7-containing region together with intronic
sequences was also PCR amplified with the help of the oligonucleotides TMEM16F_ex7d2 and
TMEM16F_ex7r2 and was consequently subcloned. The exon 7 flanking LoxP and the HindIII sites
were introduced by PCR cloning using the oligonucleotide TMEM16F_ex7r2. All clones were verified
by sequencing and assembled into the final construct (Figure 8A–D). The pBluescript-based plasmid
backbone combined with the negative selection marker (a thymidine kinase cassette and a diphtheria
toxin gene) fused to the left flanking region (not shown). The neomycin cassette flanked by two FRT
sites and one LoxP site (positive selection marker) was cloned as an EcoRI–BamHI DNA fragment
between the left flanking region and the 0.3 kb exon 7 genomic PCR clone. The phCAS9 plasmid,
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containing cas9 gene and a pgRNA-cloning vector for cloning the gRNA against the TMEM16F
mouse gene, was received through the Addgene plasmid repository. The cloning of the target
sequence AGAATCACTAATTATTAAA was performed according to previous work [38]. The 1.0 kb
HR probe (outside of the targeted homology) was PCR amplified from mouse genomic DNA using the
oligonucleotides TMEM16F_SoD1 and TMEM16F_SoR1 and subcloned.
Table 1. List of oligonucleotides used for generation of TMEM16F-knockout mice.
Genes Oligonucleotides
TMEM16F_FlAd2 GTCTCAAGCGTCTCTTGGAACGCGTATGTTCCCACAGAAGATGGATCATAACTTA
TMEM16F_FLAr2 GCTCTAGACGTCTCTGAGAGCGGCCGCTCACCACGGTGCAGCTTCATCCTA
TMEM16F_FlBd1 TGTCGACGCACCATGTTATTGGCACTAAGGA
TMEM16F_FlBr1 TGGATCCTTAGTGATTCTATAATAAGGGTGATGAT
TMEM16F_ex7d2 TGAATTCTTAAATGGCATGTCTGTCCCTTCTGG
TMEM16F_ex7r2 TACGCGTATAACTTCGTATAATGTATGCTATACGAAGTTATAAGCTTGTGTGACAGCTGCCCTGCACATAC
TMEM16F_SoD1 TTATAGAGCTGATGTCTTCACTTTGGC
TMEM16F_SoR1 AGAGTGGAGCTTTACTTTCTGACACA
CV19 ES cells (passage 13 (129Sv × C57BL/6J)) were grown in HEPES-buffered Dulbecco’s
modified Eagle’s medium supplemented with nonessential amino acids, 15% fetal bovine serum (PAA),
β-mercaptoethanol, L-glutamine, 1000 U of recombinant leukemia inhibitory factor (MERCK Millipore)
per mL, and antibiotics (penicillin (100 U/mL) and streptomycin (100 mg/mL)). For electroporation,
2 × 107 cells were resuspended in 0.8 mL Capecchi buffer (20 mM HEPES (pH 7.4), 137 mM NaCl, 5 mM
KCl, 0.7 mM Na2HPO4, 6 mM dextrose, 0.1 mM β-mercaptoethanol [39]). The pTMEM16F_targ. vector
was linearized with NotI, and 100 µg of DNA were electroporated together with the CRISPR/cas9
coding plasmids (70 µg DNA of each) at 25 µF2 and 400 V in 0.8 mm electroporation cuvettes
(Gene Pulser; Bio-Rad, Munich, Germany). Cells after electroporation were kept for 10 min at room
temperature and consequently plated onto 10 100-mm diameter culture dishes with a gamma-irradiated
monolayer of mouse fibroblast feeder cells. Thirty-two hours later, 350 µg of G418 (Invitrogen) per
mL and 0.2 mM 2′-deoxy-2′-fluoro-D-arabinofuranosyl-5-iodouracil (FIAU) (Moravek Biochemicals
and Radiochemicals, Brea, CA, USA) were added to the culture medium. The medium was replaced
every day, and colonies were picked and analyzed 8 days after plating. Positively targeted ES cell
clones were analyzed using the Southern-blot DNA method. Approximately 5–10 µg of the HindIII
digested genomic DNA samples were fractionated on 0.8% agarose gels and transferred by capillary
transport to GeneScreen nylon membranes (NEN DuPont). Membranes were hybridized with a
32P-labeled 1.0-kb probe (Figure 8A–D) and washed with 0.5× SSPE (1× SSPE is 0.18 M NaCl, 10 mM
NaH2PO4, and 1 mM EDTA (pH 7.7)) and 0.5% sodium dodecyl sulfate at 65 ◦C. After the first
screening, a correctly targeted event was confirmed on DNAs isolated from positively targeted ES cells
and with mouse tail biopsy DNAs using the same HindIII and EcoRI digestion.
Correctly targeted ES cells (clone H5) were injected into 3.5-day-old B6D2F1 blastocysts.
We injected 12 to 14 ES cells into one blastocoele. Injected blastocysts were kept in KSOM medium
(5% CO2, 37 ◦C) and afterwards transferred into the uteri of CD-1 foster mice. The mice carried pups
to term. Chimeras were identified by their agouti coat color contribution. High percentage male
chimaeras were crossed to the C57BL/6J female mice. Heterozygous agouti offsprings (TMEM16F+/−)
were confirmed by Southern blot analysis (Figure 8E). Mice were kept in specific pathogen-free animal
facilities. The subjects were male and female TMEM16F-deficient mice. All mouse procedures were
performed in compliance with the guidelines for the welfare of experimental animals issued by the
Federal Government of Germany. Pups were weaned at 19 to 23 days after birth, and females were
kept separately from males. General health checks were performed regularly in order to ensure that
any findings were not the result of deteriorating physical conditions of the animals.
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4.6. Flow Cytometry and LDH Release
PtdSer exposure was assessed using flow cytometry. Cells were removed from the culture
dishes with ice-cold PBS. After centrifugation (4 min; 1000× g), the supernatant was discarded and
Annexin V-FITC (BD Biosciences, #556419) 2.5 µL in 50 µL staining buffer (containing 1% bovine serum
albumin in 50 mM 2-(4-(2-hydroxyethyl)-1-piperazinyl)-ethansulfonic acid buffer (HEPES), pH 7.4)
was added. After vortexing, the samples were incubated on ice for 20 min. For measurements at
the BD Bioscience (FACSCanto I), 450 µL staining buffer containing DAPI 2 µM were added 5 min
prior to the measurement. A total of 50,000 cells (FACSCanto) or 10,000 cells (FACSCalibur) was
analyzed. Compensation for the channels (DAPI, FITC, RFP/PE) was calculated using the FACSDiva
software (FACScanto) or done manually (FACSCalibur). For assessment of lactate dehydrogenase
(LDH) release cells, supernatants of treated cultured cells were collected and measured using the
CytoTox96® non-radioactive cytotoxicity assay (Promega) at a wavelength of 490 nm. Percentage
of LDH release was calculated as 100× (experimental LDH-spontaneous LDH)/(maximum LDH
release-spontaneous LDH).
4.7. Animal Phenotyping
Conditional TMEM16F knockout mice were bred with the approval of the federal guidelines
for animal welfare. Mice homozygous for loxP-flanked TMEM16F were bred with mice expressing
a Six2-dependent cre-recombinase. When crossbred with Six2Cre mice, TMEM16F is constitutively
knocked out. We compared TMEM16FFF × Six2Cre mice with their cre-negative littermates. Animals
heterozygous for the floxed allele were not included in the study. Six2 is expressed in an early stage of
the kidney development, so in this knockout model tubular and glomerular epithelial cells, including
podocytes, were targeted (nephron specific knockout) [30]. The newborn mice were examined daily by
professionals. The primary endpoint of our observational study was incident proteinuria. Thus, weekly
(young mice) or twice a month (older than six months) they were weighted and spot-urine was taken
and urine electrophoresis was performed regularly. Urine was mixed with 2× Laemmli-sample buffer,
shaken, and heated at 96 ◦C for 4 min. The urine samples were loaded onto a 10% SDS gel, stained
with coomassie brilliant blue R-250 solution (Sigma-Aldrich, Munich, Germany) for 30 min, and finally
destained overnight. Animals were sacrificed at the age of 12 months. At this final time point, urine
and whole blood was collected. For both, urine and serum, sodium, potassium, and chloride were
measured with an ion-sensitive electrode. Calcium, phosphate, creatinine, magnesium, and protein
were measured with a photometric assay, and urea was assessed with an enzymatic photometric test.
Kidneys were harvested and one kidney was fixed in 4% paraformaldehyde (pH 7.4) for 24 h and then
processed for histology. The other kidney was cut into three slices and snap-frozen.
4.8. TUNEL Assay
Terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) assays were performed
as described earlier [40]. In brief, the DeadEnd Fluorometrie TUNEL system (Promega, Mannheim,
Germany) was used according to the manufacturer’s instructions. Immunofluorescence was detected
using an Axiovert 200 microscope equipped with ApoTome. Immunofluorescence was analysed
quantitatively using Axio-Vision software (Zeiss, Munich, Germany).
4.9. Calcium Measurements
Intracellular Ca2+ concentrations were assessed in AB8 podocytes using Fura2 fluorescence as
described earlier. Cells were seeded on glass cover slips and loaded with 2 µM Fura-2/AM and 0.02%
Pluronic F-127 (Invitrogen, Darmstadt, Germany) in ringer solution (mmoL/L: NaCl 145; KH2PO4 0,4;
K2HPO4 1,6; Glucose 5; MgCl2 1; Ca2 ± Gluconat 1,3) for 1 h at room temperature. Fluorescence was
detected in cells perfused with Ringer’s solution at 37 ◦C using an inverted microscope (Axiovert S100,
Zeiss, city, Germany) and a high-speed polychromator system (VisiChrome, Puchheim, Germany).
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Fura-2 was excited at 340/380 nm, and emission was recorded between 470 and 550 nm using a
CoolSnap camera (CoolSnap HQ, Visitron, Puchheim, Germany). [Ca2+]i was calculated from the
340/380 nm fluorescence ratio after background subtraction. The formula used to calculate [Ca2+]i
was [Ca2+]i = Kd × (R − Rmin)/(Rmax − R) × (Sf2/Sb2), where R is the observed fluorescence ratio.
The values Rmax and Rmin (maximum and minimum ratios) and the constant Sf2/Sb2 (fluorescence
of free and Ca2 ± bound Fura-2 at 380 nm) were calculated using 1 µM ionomycin (Calbiochem), 5 µM
nigericin, 10 µM monensin (Sigma), and 5 mM EGTA to equilibrate intracellular and extracellular
Ca2+ in intact Fura-2-loaded cells. The dissociation constant for the Fura-2·Ca2+ complex was taken
as 224 nmoL/L. Control of experiments, imaging acquisition, and data analysis were done with
the software package Meta-Fluor (Molecular Devices, San Jose, CA, USA) and Origin (OriginLab
Corporation, Northampton, MA, USA).
4.10. Patch Clamping
Patch clamp experiments were performed as described earlier [41]. In brief, patch pipettes
were filled with a cytosolic-like solution containing in mM: KCl 30, K-gluconate 95, NaH2PO4 1.2,
Na2HPO4 4.8, EGTA 1, Ca-gluconate 0.758, MgCl2 1.03, D-glucose 5, ATP 3, pH 7.2. TMEM16A
was activated by high-pipette Ca2+ (1 µM). Extracellular Cl− (145 mM) was replaced by gluconate,
HCO3−, or I−. Shifts in the reversal potential of current voltage relationships were used to calculate
permeability ratios. (Pipette solution 145 mM). Coverslips were mounted in a perfused bath chamber
on the stage of an inverted microscope (IM35, Zeiss) and kept at 37 ◦C. The bath was perfused
continuously with Ringer solution at a rate of 8 mL/min. Patch clamp experiments were performed
in the fast whole-cell configuration. Patch pipettes had an input resistance of 2–4 MΩ when filled
with cytosolic-like solution. Currents were corrected for serial resistance. Access conductances were
monitored continuously and were 60–140 nS. Currents (voltage clamp) and voltages (current clamp)
were recorded using a patch clamp amplifier (EPC 7, List Medical Electronics, Darmstadt, Germany),
the LIH1600 interface and PULSE software (HEKA, Lambrecht, Germany), as well as Chart software
(AD Instruments, Spechbach, Germany). Data were stored continuously on a computer hard disc and
analyzed using PULSE software. In regular intervals, membrane voltages (Vc) were clamped from
−100 to +100 mV in steps of 20 mV (holding voltage of −100 mV). Current densities were calculated
by dividing whole-cell currents by cell capacitance.
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